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Summary.-Four albumin conjugates of oestradiol. labelled with fluorescein or
peroxidase to permit visualization under light or fluorescence microscopy, were
synthesized. These were used to examine the feasibility ofidentifying oestrogen bind-
ing infrozen section bytwo publishedhistochemical techniques. In avarietyofexperi-
mental tissues and human breast cancers, binding of the oestrogen conjugates was
demonstrable, but it appeared nonspecific (i.e., rarely displaceable by competitor)
and unrelated to oestrogen receptor (RE) status of the tissue as determined bio-
chemically by assay with dextran-coated charcoal.
Investigation of the fate of the RE through the various steps of a histochemical
assay, demonstrated major losses of RE from unfixed tissue or after tissue fixation.
The RE also exhibited a 10-50-fold poorer affinity for the conjugates synthesized than
for oestradiol-173 and, at the concentrations of conjugate routinely used in histo-
chemical assays, it seems likely that considerable nonspecific binding takes place.
These factors may combine to make it (1) difficult to implement such histochemical
assays and (2) unlikely that the RE is being detected.
IT IS NOW WELL ESTABLISHED that the
determination of the oestrogen receptor
(RE) content of breast-cancer specimens
is of value in planning therapy (Hawkins
et al., 1980). Techniques in current use
for RE assay involve the homogenization
of a sizeable portion of tumour (160-250
mg preferred in our laboratory) and are
expensive in terms of equipment, radio-
active reagents and technicians' time.
Recognition ofthese and other limitations
of current biochemical methods has led
several groups to investigate techniques
for the identification of RE in frozen
section by immunohistological or histo-
chemical means (Nenci et al., 1976;
Mercer et al., 1978, 1979; Pertschuk et al.,
1979; Lee, 1979; Walker et al., 1980).
Using histochemical methods, at least
two groups (Pertschuk et al., 1979;
Walker et al., 1980) have reported a good
correlation with the results ofbiochemical
RE assays using dextran-coated charcoal
(DCC) or sucrose density gradient (SDG).
Such histochemical techniques are of
potential clinical value, since little tumour
tissue is required and allowance can be
made for tumour heterogeneity. In setting
up a histochemical system for the identifi-
cation ofthe RE protein, several technica]
andtheoretical problemsmustbeovercome
Firstly, the fact that RE is a component
of the soluble cytoplasm may allow it to
"leach out" into aqueous processing
media from unfixed cells disrupted by
the cutting of frozen sections; this
possibility has recently been discussed
by McCarthy et al. (1980). Secondly, the
ability of RE to bind to oestrogen is well
recognized as a labile property which
might be well impaired if fixative were
used to immobilize RE within the tissue
section. Thirdly, the conjugation ofoestra-
diol to tracers which can be visualized
histochemically might seriously impair
the binding of the oestradiol moiety to28. C. PENNEY AND R. A. HAWKINS
RE. Lastly, the concentrations of oestra-
diol conjugates and of competitive re-
ceptor-blockers advocated for histochemi-
cal techniques are so high that binding
may not be limited to the high-affinity RE,
but might also occur at nonspecific binding
sites.
In this paper we report on our experience
with the histochemical techniques of
Pertschuk et al. (1 979) and Walker et al.
(1980) and alsoonourfindings in relation to
the 4 technical problems outlined above.
MATERIALS AND) METHODS
Oestradiol-17/-BSA-ftuoresceinconjugates.-
Conjugates were prepared by the mixed-an-
hydride method of Erlanger et al. (1957).
Briefly, oestradiol-17/ hemisuccinate (Sigma)
was activated by reaction with tri-n-butyl-
amine and isobutylchlorocarbonate in dioxane
and then bovine serum albumin (BSA) was
added to the reaction mixture. After dialysis,
the resulting oestradiol-BSA conjugate was
allowed to react with fluorescein isothiocya-
nate (FITC. Baltimore Biological Laborator-
ies) and again dialysed. Two conjugate
preparations of this type were used. The
first was a gift from Dr L. Pertschuk and
contained 4 mol of oestradiol (linked via
the C17 position) and 5 mol of fluorescein
per mole of BSA. The second was synthesized
by us using the same method. Both were
used at a final concentration of 50 ,tg/ml
(equivalent to 370 nm with respect to the
entire conjugate molecule). In addition, a
conjugate comprising only BSA and FITC
was synthesized for the assessment of non-
specific fluorescein-labelling of tissues due
to binding of BSA.
Oesteradiol-17f-BSA-per-oxidase conjugates.
Conjugates were prepared by the methods
ofNakane & Kawaoi (1974) and of Avrameas
& Ternynck (1971). In the former, reactive
aldehyde groups were created by reaction
of horseradish peroxidase (HRP, type IV.
Sigma) with sodium periodate. After dialysis.
the resulting aldehyde mixture wias allowed
to react with 173-oestradiol-6-0-carboxv-
methyloxime-BSA (from Steraloids: 33 mol
of steroid/mol BSA). The resulting conjugate
was stabilized by sodium borohydride treat-
ment and purified by dialysis and final
chromatographv on a 100 x 1 2cm columnl
of Sephadex G10( to remove low-mol.-wt
precursors. In the second method, the
reactive aldehyde groups were created by
reaction of HRP with glutaraldehyde, the
product ofactivated peroxidase being purified
by chromatography on a 60 x 1 2cm column
of Sephadex G25. The purified product was
allowed to react with 17fl-oestradiol-6-0-
carboxy-methyloxime-BSA, and the resulting
conjugate was stabilized by the addition of
lysine, dialysed and purified by chromato-
graphy as above. These methods are reported
to combine 1-4 mol of HRP with each mole
of the BSA-steroid conjugate. The final
conjugate concentrations were determined
empirically by preliminary straining of
sections of rat uterus: determination of the
protein concentration (Bradford, 1976) of
these solutions indicated a final concentra-
tion of - 1 5,UM with respect to the entire
conjugate molecule. In all, 3 syntheses were
undertaken, one by the first method and two
by the second.
Biochemical assay of RE.-The DCC assay
of Hawkins et al. (1977) was used for human
and rat tissues with one modification: the
assay medium comprised Tris buffer (0-25M
sucrose, 10mM tris. 1mM ethylene diamine
tetra-acetate. pH 8 0 at 25°C) to which
had been added glycerol (10% v/v) and
mnonothioglycerol (1% v/v). Results were
expressed as fmoles of RE binding sites/
mg tissue. derived by Scatchard analysis.
Histochemical assessment of oestrogen bind-
ing using fluorescein tracer.-The method
of Pertschuk et al. (1979) was followed.
Briefly, frozen 4um sections were cut,
air-dried on to glass slides and incubated, in a
humidifier chamber at room temperature,
in solutions of oestradiol-BSA-fluorescein
conjugate (50 ,tg/ml). To demonstrate specifi-
city of binding, additional sections were
incubated with conjugate plus an excess
(100 ,ug/ml) of an unlabelled competitive
receptor-blocker (the anti-oestrogen C1628
(Parke Davies) or diethylstilboestrol (DES).
After incubation, the sections were rinsed,
fixedfor 10min inethanol/acetone,extensively
washed and mounted in buffered glycerol.
The sections were then examined under
incident UV light for cellular fluorescence,
which was diminished in control sections
incubated in the presence of both conjugate
and competitor. Further control sections
were incubated with a solution of BSA-
fluorescein (50jtg/ml).
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Histochernical assessment ofoestrogenbinding
asing peroxidase tracer.-The method of
Walker et al. (1980) was followed. Briefly
4,um frozen sections, mounted on glass
slides, were fixed by immersion in acetone
for 4 min at room temperature. The sections
were then incubated for 2 h in a humidifier
chamber at room temperature in solutions of
BSA-peroxidase conjugate (- 1-5 EM). Con-
trol sections were incubated with conjugate
plus an excess of unlabelled, competitive
receptor blocker (usually DES, but occasion-
allyC1628 orTamoxifen)in saturatedsolution.
Following incubation, the slides were ex-
tensively washed in PBS and exposed to
diaminobenzidine tetrahydrochloride plus
H202 for the demonstration of peroxidase.
Further controls consisted of similar sections
exposed directly to the diaminobenzidine
mixture to demonstrate endogenous peroxi-
dase. All sections were again washed, counter-
stained with haematoxylin, dehydrated,
cleared aind mounted for light microscopy.
A series of tissues were assayed for RE by
the biochemical method and also processed
histochemically. The slides were scored for
intensity of staining by one of us (G.C.P.)
without prior knowledge of the biochemical
result.
Investigationt of losses of RE during section
cutting.-To study possible losses of RE
due to histochemical processing of specimens,
RE-rich tissues (rat uteri and DMBA-
induced rat mammary tuinours) w-ere assayed
for RE with and without being subjected to
various steps of histochemical techniques.
Firstly, the effect of simply cutting a portion
of tissue into 4,um frozen sections and,
secondly, the effect of exposing unfixed
4[m and 14ym sections to aqueous buffer
were investigated. In the latter case, both
the sections and the buffers to wNhich they
had been exposed wAere assayed for RE.
Investigation of losses of RE during fix-
ation.-Two different fixation processes were
studied -with regard to their effects on RE:
firstly. fixation in acetone for 4 min before
incubating the tissue with steroid (Walker
et al.. 1980) and secondly, fixation in ethanol/
acetone for 10 min after incubation (Pertschuk
et al.. 1979).
Rat uteri wzere exposed to acetone. hiomog-
enized in buffer and centrifuged to yield
a cytosol and an insoluble pellet. Both the
cytosol and the pellet were then assayed for
RE, the first biy the standard biochemical
method and the latter by incubation of
aliquots of the pellet with mixtures of
tritiated and unlabelled oestradiol, followed
by removal of unbound steroid by washing
the pellet in buffer (based on the method
of Anderson et al., 1972).
To study fixation with ethanol/acetone.
an RE-rich tissue (DMBA-induced rat mam-
mary tumour) was cut into slices (- 0 5 mm
thick) which were incubated for 1 h at 25TC
in Krebs bicarbonate buffer containing
3H-oestradiol (0.18 nM) with or without
excess unlabelled oestradiol (92 nM). (These
conditions should effect a specific uptake
of 3H-oestradiol into the cell nucleus-
Hawkins et al., 1978). After incubation and
brief rinsing in buffer, the slices were im-
mersed in the fixative for 10 min, then
extensively washed in buffer. Control slices
w%ere processed similarly but omitting the
fixation step. All slices were then digested
in 5N NaOH and mixed with aqueous
scintillator to permit determination of 3H
uptake by scintillation counting.
Determination of relative binding affinities of
oestradiol conjugates and parent compounds.-
Successive steps in the synthesis ofconjugates
of oestradiol with tracers suitable for histo-
chemical localization increase the size of
the molecule. The effects of these steps on
the ability of the 17/-oestradiol moiety
to bind to RE w^ere examined by competitive-
binding studies. Varying concentrations of
the compound under test (0'01 to 10,000
molar excess) were allowed to compete with a
fixed concentration of 3H-oestradiol (0 03 nM)
for binding to aliquots of an RE-rich cytosol.
prepared from pooled rat uteri, during an
overnight incubation at 4°C. Free and bound
hormone were then separated by charcoal
adsorption, as described by Hawkins et al.
(1977).
The increasing displacement of 3H-oest-
radiol from cytosolic receptor sites by
increasing concentrations of the various
test compounds was plotted and compared
wvith the displacement produced by equivalent
concentrations of 17f-oestradiol. Relative
binding affinities (RA) were then calculated
as:
conicentration of 17/-oestradiol
for 5000/' displacement
concentration of test compound
for 5000 displacement
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RESULTS
Histochemical assessment of oestrogen-bind-
ing using fluorescein tracer
The histochemical technique of
Pertschuk et al. (1979) was applied to a
range of human and rat tissues which
had been designated RE+ or RE- by bio-
chemical assay. Morphologically similar
RE+ and RE- tissues (rat uterus and
duodenum) exhibited widespread fluores-
cent labelling ofremarkably similar distri-
bution. Inneither casewasthefluorescence
diminished by the presence of either
DES or the anti-oestrogen, CI 628, even
when the concentration of competitor
was increased to the point of sturation.
Widespread fluorescent labelling which
could not be "blocked" by the presence
of competitors was also seen in all speci-
TABLE I.-Summary of results ofDCC assaysfor RE and ofhistochemical staining using
oestradiol-BSA-peroxidase in 17 tissues without endogenous peroxidase.
Tissue
Uterus
Uterus
Uterus
Uterus
Ovarian
metastatis (L)
from breast
cancer
10 Breast cancer
10 Breast cancer
10 Breast cancer
10 Breast cancer
Patient 1 Ovarian
metastasis (R)
10 Breast cancer
Benign mammary
dysplasia
10 Breast cancer
10 Breast cancer
Cytosarcoma
Squamous
epithelium of
ear
Cheek muscle
Histochemical assay result
DCC , A
assay Degree of peroxidase
result* Assay no. staining (0 to + + +)
14-9 1
2
13-9 1
2
3
13-3 1
+ ++ +mainly in
++ + f endometrium
+ -all layers
+ + all layers
10-2 1 + + + mainly in
ectocervical squamous
epithelium
7-4 1 +++
6-0 1
5-0 1
4-7 1
3-6 1
2
3
1-7 1
2
3
4
1-7 1
0-6 1
0
0
0
0
1
1
+ + (stroma> cells)
} +++ within
cancer cells only
++
0
0
+
± (stroma >cells)
0
0
0 1 ++
Agreement
between
DCC and
Blocking by histochemical
competitor"* assays
partial
none
none
?t
none
partial
?
none
9
9
9
total
partial
I?
none
none
none
+
9
9
?
+
I
9
9
+
+
none
* fmoles receptor/mg tissue.
** The competitor used was a saturated solution of DES in 21 assays, or Tamoxifen in 2 assays and of
CI-628 in 2 assays.
t Indicates that tissue architecture was disrupted by high concentration of competitor, making assessment
of blocking impossible.
t Agreement between the two assay techniques has been assessed as follows:
+Positive staining with convincing blocking in tissues designated RE-rich by DCC assay or absent
staining in tissues designated RE-poor by DCC assay.
-Absent staining in tissues designated RE-rich by DCC assay or positive staining in tissues designated
RE-poor by DCC assay.
?Positive staining but unconvincing blocking in tissues designated RE-rich on DCC assay.
Subject
Rat A
(lactating)
Rat B
(lactating)
Rat C
(immature)
Rat D
(immature)
Patient 1
Patient 2
Patient 3
Patient 4
Patient 5
Patient 6
Patient 7
Patient 8
Patient 9
Patient 10
Rat E
Rat F
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mens of human and rat mammary
tumours examined. Incubation of sections
with oestrogen-free, BSA-fluorescein con-
jugate also produced widespread, but
slightly less intense, fluorescence.
Histochemical assessment of oestrogen-bind-
ing using peroxidase tracer
All 3 synthesized preparations of oestra-
diol-BSA-peroxidase conjugate were effec-
tive in producing some staining of sections
at dilutions of 1/8 to 1/20 of the final
eluate from gel filtration. Higher concen-
trations resulted in heavy deposition
over the entire section. Various human
and rat tissues were studied by the
method of Walker et al. (1980). Staining
due to endogenous peroxidase was found
to be abundant in sections of human
uterus and rat duodenum, and these
tissues were therefore considered un-
suitable for study by the peroxidase
tracer technique, as it would have proved
impossible to distinguish between "endo-
genous" and "tracer" peroxidases. The
microscopic appearances found in 25
histochemical assays on 17 tissues, in
which interpretation was not complicated
by the presence of endogenous peroxidase
staining, are summarized in Table I.
In all 19 assays on tissues which had
high or moderate RE levels on biochemical
assessment, cellular uptake of conjugates
was demonstrable. However, reproduci-
bility was poor, and in only 4 of those 19
cases could such uptake be diminished by
the presence of an unlabelled competitor
("blocking"). Even in these 4 cases,
the competitor had to be used in saturated
solution to achieve blocking. Cellular
uptake ofconjugate was also demonstrable
in many tissues which were RE poor by
biochemical assay; blocking was not
demonstrable in any of these tissues.
Cellular uptake of conjugate was absent
from only 2 ofthe 6 tissues which were RE-
poor biochemically. Overall, therefore,
agreement with biochemical assay was
obtained in only 6/25 assays: 4 RE-rich
tissues where cellular uptake occurred,
and could be blocked, and 2 RE-poor
tissues where no uptake occurred.
Loss of REfrom unfixed tissues
Portions of rat uterus were homogenized
and assayed for RE, "intact" or after
cutting into 4rm cryostat sections. This
revealed a concentration of RE in the
"intact" portion of 6 69 fmol/mg tissue,
but only 2-45 fmol/mg tissue in the
"sectioned" portion, a loss of over 5000
ofdetectable RE.
Frozen sections of tissue were exposed
to aqueous processing media and RE
assays performed on the sections and
media after separation by gentle centri-
fugation. The results of these assays, on
4pim and 14,am sections, and their res-
pective media, are shown in Fig 1.
In the case of 4ftm sections, RE activity
in the washing buffer was 4 x that
remaining in the sections and, in the
case of 14km sections, was 3 x as great.
Thus, it is evident that RE is very
readily lost from unfixed tissues.
07- \
bound
free 06-\
0 1 2 3 4 5 6 7
total mass bound ( pg)
FIG. 1. Scatchard plots of data from RE
assays performed on eytosols prepared
from 4,um and 14,4m frozen sections of
DMBA-induced rat mammary tumour and
on aliquots of buffer in which the sections
had been washed. 0, washing buffer from
4,um sections. A, washing buffer from
14/gLm sections. A cytosol prepared from
14,m sections. *, cytosol prepared from
4,um sections.
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Fi. 2.- Scatchard plots of data from RE
assays performed on (ytosols and pellets
prepared from rat uteri, after fixation in
acetone or uinfixed 3 cytosol. preparedt
from unfixed utei. 0;pellet prepared from
acetone-fixed uteri. A. cytosol prepare"
from acetonefixedt uteri. (No RE was
(letectable in the pellet prepared from
tinfixed uteri). N.B. Results of cytosol an(l
pellet assays are not directly comparable as
reagent (oncentrations were not idientical.
Loss of RE duringfixation
Acetone.-When rat uteri were exposed
to either acetone or buffer for 4 min,
homogenized and separated into cytosol
and pellet for RE-assay, no activity was
dletectable in the pellet preparation from
the tinfixed (buffer-exposed) specimen.
The other 3 preparations (acetone-fixed
cvtosol, acetone-fixed pellet and unfixed
cytosol) contained RE and Scatchard
plots for the assay's ofthese are reproduced
in Fig. 2. After acetone fixation, both
concentration and apparent affinity of
RE binding were markedly impaired, bv
comparison with the cytosolic RE of the
TABLE II.-The effect of ethanol/acetone
post-fixation onuptakce ofoestradiol 17/ by
slices of DMBA-induced rat maimnmary
titnuour. Each result represents the mean
of 2 similarly treated flasks of sections
Form of Steroid content of
fixation incubation mediuim
None 3H-oestradiol only
labelled and excess
unlabelled oestradiol
Ethanol/ 3H-oestradiol only
acetone labelled and excess
tinlabelled oestradiol
Counts bouri
(ct/min/mg
unfixed specimen. 'l'he total RE concentra-
tion (pellet plus cytosol) detectable in the
acetone-treated specimen was less than
half that detectable in the cytosol from
the untreated tissue. Thus, acetone-
fixation appears to destroy at least 5000
of the receptor present.
Ethanol/Acetone. In unfixed 05mm
tissue slices of DMBA-induced tumour,
marked uptake of 3H occurred after
incubation with 3H-oestradiol alone. Such
uptake was diminished by almost 75%0
in slices incubated with 3H-oestradiol
plus excess, unlabelled oestradiol. This
differential labelling was regarded as
indicative of RE. In tissuie slices which
had been fixed in ethanol/acetone after
incubation with steroid, minimal uptake
of 3H-oestradiol was detectable, and there
was no differential labelling between
slices incubated with 3H-oestradiol alone
and those incubated in the presence of
unlabelled oestradiol (see Table II). This
finding suggested that any binding of
steroid to tissue which had occurred
during the incubation period had been
abolished by exposure to the fixative.
Relative binding affinities (RA) ofoestradiol
conjugates and parent comnpounds
The following 7 compounds were subjected
to competitive-binding studies: I 7/3-oestra-
diol, the parent molecule: two prepara-
TABLE III.--Relative binding affinities
(RA) of conjugates and conjugate pre-
cursors used for RE histochemistry.
Binding affinities relate to the molar
concentration of each compound which
causes 50% inhibition of 3H-oestradiol
binding, on a basis of oestradiol 17f/= =
(w,here conjugate concentrations refer to
molarity of the entire conjugate molecule
rather than oestradiol moieties).
Compound RA
isUte) Oestradiol 17,B 1 0
183 Oestradiol-BSA-Fluoiescein (Pertschuk) 0.8
51 Oestradiol-BSA-Fluoreseein (present auitlhors) 0 05
BSA-Fluorescein 0*00
4 6-keto-oestradiol 17f 0 13
6 6-keto-oestradiol-BSA 009
6-ket,o-.oestradiol-BSA-peroxidase O 02
2 )42-
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1001
('H]E.
bound 5.
0i
EaB-SA-fl_uSof
a-BSA-fl oi
01 0-1 1 .010 100 i000
maoor ratio of co ipo ttor (3HE5 .
Fin. :3. Curves illustrating the binding
of C17-linked oestradiol conjugates and
of a conjugate of BSA and fluorescein
alone to the RE, elative to that foi
oestradiol 17f. Curves show the increasing
dlisplacement of a fixed concentration
(0OO3nM) of 3H-oestradiol by increasing
concentrations of the compound under test.
Figures on the Xvertical axis indicate the
binding of 3H-oestradiol as a percentage
of the total bound in the absence of'
competitor. O O, Oestradiol- 17,B.
O , Oestradiol-BSA-Fluorescein-
supplied by L. Pertschuk. A A,
Oestradiol-BSA-Fluorescein synthesized
in our lab. A, BSA-Fluorescein-
synthesized in ouir lab.
* oatoro;
ofs, ti !E.E.
1Fta. 4.--Curves illustrating the binding
of C6-linked oestradiol conjugates to the
RE, relative to that for oestradiol 17,B.
Curves show the increasing (lisplacement
of a fixed concentratioin (OO3nAi) of
3H-oestradiol by increasing concentrations
of the compound under test. Figuires on the
v,ertical axis indicate the binding of 3H-
oestradiol as a percentage of the total
bound in the absence of competitor.
O, oestradiol 17P. x, 6-keto-oestradiol
17fl. A, 6-keto-oestra(liol-BSA. 6-keto-
oestradiol-BSA-peroxidase.
tions of oestradiol-BSA-fluorescein con-
jugated via C17 (one synthesized bY
lus and one donated by Dr L.
Pertschuk); a conjugate of BSA and
fluorescein alone; 6-keto-oestradiol, the
precursor of conjugates utilizing the C6
position; oestradiol-BSA conjugated via
C6 (Steraloids) and oestradiol-BSA-perox-
idase (synthesized by us from this
precursor). Binding curves for the
C17 and C6 conjugates are shown in
Figs 3 & 4 respectively, and the RAs of
the compounds tested are listed in Table
III. Successive conjugations to the 17f-
oestradiol moiety via C6 diminished the
RA. The conjugates prepared via C17,
particularly that donated by Dr L.
Pertschuk, exhibited higher binding affin-
ities.
D)ISCUSSION
Histochemical technique in practice
In our hands, the main problems en-
countered during attempts to reproduce
the fluorescein tracer technique of
Pertschuk et al. (1979) was the widespread
uptake of conjugate, which could not
be diminished by the presence of com-
petitors, in all the tissues studied. This
finding may be related to the form of
fixation used in this technique. The
experiment described in this paper, in
which 3H-oestradiol was used to study
the effects of ethanol/acetone fixation on
RE binding, suggests that such fixation
might cause disruption of the oestradiol-
RE bond.Thus, fixation in ethanol/acetone
after incubation of frozen sections with
conjugate (as in Pertschuk's technique)
might disrupt any binding to RE which
has occurred during the incubation period,
as well as serving to immobilize the
protein-containing conjugate wherever it
lies in the section.
Attempts to reproduce the peroxidase
tracer technique of Walker et al. (1980)
resulted in binding of conjugate which
did, in some instances, appear to be
"specific", in that it was diminished by
the presence of a competitor. However,
when the method was repeated on the
same tissue on several occasions, repro-
ducibility was poor, as was correlation
between the results of the histochemical
technique and those ofbiochemical assays.
Trhese disappointing results may have
arisen from a combination of the losses
of RE accruing from histochemical proces-
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TABLE IV.-Summary of the sites and magnitudes of losses of RE which may occur w:hen
tissues are exposed to histochemical processing.
Process
Section cutting
Exposure of unfixed
tissue to aqueous media
Fixation in acetone
Fixation in acetone
Fixation in glutaraldehyde
Fixation in formaldehyde
Fixation in formaldehyde
"Post-fixation" in
ethanol/acetone
sing, the low binding affinities ofoestradiol
conjugates and a high degree of non-
specific binding resulting from the use
of high conjugate concentrations.
Losses of RE
Losses of RE may occur at several of the
stages of histochemical procedures. These
losses, as calculated from the present
work and from the studies of others,
are summarized in Table IV. In our hands,
the steps involved in the technique of
Walker et al. (1980) might allow some
25% of the RE originally in the tissue to
remain "viable", but a procedure incorpo-
rating the ethanol/acetone fixation step
of Pertschuk et al. (1979) might totally
abolish any specific RE activity.
Binding affinities of conjugates
Conjugates which have been advocated
for RE histochemistry can be divided
into two main groups: those where the
oestradiol moiety is linked to the tracer
via the C6 position (e.g. that of Walker
et al., 1980) and those linked via C17
(e.g. that of Pertschuk et al., 1979).
Theoretical considerations concerning the
postulated site of the oestradiol-RE bond
(Ellis & Ringold, 1971) and the mainten-
ance of the antigenecity of oestradiol
(Lindner et al., 1972) would favour the
C6 position as the site of conjugation.
However our own results (Table III)
and those of Dandliker et al. (1978)
indicate that, in practice, conjugation via
C17 shows superior binding affinities.
Indeed, the RA of 0-8 obtained for the
Author
Present work
Present work
Present woirk
Lee (1978)
Lee (1978)
Lee (1978)
Dandliker et al.
(1978)
Present work
0 Loss
50
66-75
50
"Complete"
"Complete"
"Complete"
60-80
Almost total
sample of oestradiol-BSA-fluorescein pro-
vided by Dr L. Pertschuk is strikingly
superior to those of the other compounds
examined. However, this RA must be
interpreted with some caution, in view
of the point raised by Dandliker et al.
(1978) that a small amount of an active
contaminant, or a small amount of
degradation liberating free, unlabelled
hormone, could lead to an inflated
estimate of RA.
The RA of only 0-02 obtained for the
C6-linked conjugate of Walker et al.
may account, at least in part, for the
disappointing results with their technique
It was encouraging to note that the
compound containing only BSA and
fluorescein failed to inhibit binding of
3H-oestradiol to RE, which suggests that
the inhibition produced by the oestradiol-
containing conjugates was notnon-specific,
i.e. due simply to the presence of material
of high molecular weight.
Concentration of conjugates
For RE assay systems in general, it is
felt that a concentration of labelled
oestradiol which is adequate to saturate
the receptors, but not vastly in excess
of the saturating concentration, should be
used. Concentrations of 1-5nM (McGuire
et al., 1977; King et al., 1979) have been
advocated as appropriate for biochemical
techniques using a single, saturating
dose of labelled oestradiol. If a concentra-
tion vastly in excess of that needed for
saturation is used, binding to non-
specific proteins (e.g. albumin, Kd=
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10-4 to 10-5) is increased. Such binding
may be confused with specific RE,
in that it may be inhibited by the presence
of an even higher concentration of com-
petitor.
The concentrations oflabelled oestradiol
in the various histochemical techniques
are very much higher than the 1-5nM
suggested for RE saturation. Pertschuk
et al. (1979) used a conjugate concen-
tration of 370nM (1480nm with respect
to the oestradiol moieties). Lee (1979) used
a conjugate concentration of46 puM (1 1 mm
with respect to oestradiol). The approxi-
mate conjugate and oestradiol concentra-
tions used by Walker et al. (1980) were
1-5)M and 50 pM respectively (estimates
based on protein assays carried out by
the present authors). At concentrations
such as these, binding to low-affinity
sites would almost certainly occur, leading
to difficulties in interpreting the results.
In summary, there is wide agreement
that a reliable and reproducible technique
for the identification of RE in histological
sections would represent a significant
advance over currently available bio-
chemical assays. From the good correla-
tion with the results of biochemical
assays reported by at least two groups,
it would seem that such a histochemical
technique may, indeed, be a reality.
However, the losses of RE inherent in
histochemical processing, the low binding
affinities of many oestradiol conjugates,
and the inconsistency between the con-
centrations of conjugates and competitors
used and the known binding affinity of
RE, mustraise serious doubts that true RE
is being demonstarated. It seem possible
that binding to another oestrogen-bin-
ding protein of lower affinity (perhaps
the Type II or Type III receptor sug-
gested by Chamness et al., 1980) is being
demonstrated, and that binding to this
protein may, in turn, correlate with
biochemically-estimated RE activity.
However, the difficulties which we have
experienced, plus the lack of reported
success with such methods from other
centres, would argue that, at the
present time, histochemical detection of
oestrogen-binding is technically too diffi-
cult for general use.
We would like to thank Professor A. P. M. Forrest
for his support and encouragement, Mr Walter
Hawkins for technical assistance in frozen section
cutting, Dr L. P. Pertschuk, Department of
Pathology, King's- County Hospital, Brooklyn, New
York, for a gift of his conjugate, Dr R. A.
Walker, Department of Pathology, University of
Birmingham, for personal instruction in her method,
Professor C. W. Horn, Department of Pathology,
University of Aberdeen, for helpful discussions and
the Tenovus organization for grant support to
G.C.P.
REFERENCES
ANDERSON, J., CLARK, J. H. & PECK, E. J. (1972)
Oestrogen and nuclear binding sites: Determina-
tion for specific sites by (3H) oestradiol exchange.
Biochem. J., 126, 561.
AVRAMEAS, S., & TERNYNCK, T. (1971) Peroxidase
labelled antibody and Fab conjugates with
enhanced intracellular penetration. Immunology,
8, 1175.
BRADFORD, M. M. (1976) A rapid and sensitive
method for the quantitation of microgram
quantities of protein utilizing the principle of
protein-dye binding. Anal Biochem, 72, 248.
CHAMNESS, G. C., MERCER, W. D. & McGUIRE, W. L.
(1980) Are histochemical methods for oestrogen
receptor valid. J. Hi8tochem. Cytochem., 28, 792.
DANDLIKER, W. B., BRAWN, R. J., Hsu, M. L.,
LEvIN, J., MEYERS, C. Y. & KOLB, V. M. (1978)
Investigation of hormone-receptor interactions
by means of fluorescence labelling. Cancer Res.,
38, 4212.
ELLIS, D. J. & RINGOLD, H. J. (1971) The uterine
oestrogen receptor: A physicochemical study.
In The Sex Steroids (Ed. McKerns). New York:
Appleton-Century-Crofts. p. 73.
ERLANGER, B. F., BOREK, E., BEISTER, S. M. &
LIEBERMAN, S. (1957) Preparation and characteri-
sation of conjugates of BSA with testosterone
and cortisone. J. Biol. Chem., 228, 713.
HAWKINS, R. A., HILL, A., FREEDMAN, B. & 4
others (1977) Oestrogen receptor activity and
endocrine status in DMBA-induced rat mam-
mary tumours. Eur. J. Cancer, 13, 223.
HAWKINS, R. A., ROBERTS, M. M. & FORREST,
A. P. M. (1980) Oestrogen receptors and breast
cancer: Current status. Br. J. Surg, 67, 153.
HAWKINS, R. A., SCOTT, K. M. & FREEDMAN, B.
(1978) Oestrogen receptor activity and intramus-
cular translocation in ovarian-dependent and
independant rat mammary tumours. J. Endo-
crinol., 77, 63P.
KING, R. J. B., REDGRAVE, S., HAYWARD, J. L.,
MILLIS, R. R. & RUBENS, R. D. (1979) The
measurement of receptors for oestrogen and
progesterone in human breast tumours. In
Steroid ReceptorAssays inHuman Breast Tumour8:
Methodological and Clinical Aspects (Ed. King).
Cardiff: Alpha Omega.
LEE, S. H. (1978) Cytochemical study of oestrogen
receptor in human mammary cancer. Am. J. Clin.
Pathol., 70, 197.
17246 G. C. PENNEY AND R. A. HAWKINS
LINDNER, H. R., PEREL, E., FRIEDLANDER, A. &
ZEITLIN, A. (1972) Specificity of antibodies to
ovarian hormones in relation to the site of
attachment of the steroid hapten to the peptide
carrier. Steroids, 19, 357.
MCCARTHY, K. S., WOODARD, B. H., NICHOLS, D. E.,
WILKINSON, W. & MCCARTHY, K. S. (1980)
Comparison of biochemical and histochemical
techniques of oestrogen receptor analyses in
mammary carcinoma. Cancer, 46, 2842.
MCGUIRE, W. L., DE LA GARZA, M. & CHAMNESS,
G. C. (1977) Evaluation of oestrogen receptor
assay in human breast cancer tissue. Cancer
Res, 37, 637.
MERCER, W. D., CARLSON, C. A., WAHL, T. M. &
TEAGUE, P. 0. (1978) Identification of oestrogen
receptors in mammary cancer cells by immuno-
fluorescence. Am. J. Clin. Path. 70, 330.
MERCER, W. D., WAHL, T. M. & TEAGUE, P. 0.
(1979) Identification of oestrogen receptors in
breast cancer cells by immunological techniques.
Proc. Am. A88oc. Cancer. Re8., 20, 332.
NAKANE, P. N. & KAWAOI, A. (1974) Peroxidase-
labelled antibody: a new method of conjugation.
J. Histochem. Cytochem., 22, 1084.
NENCI, J., BECCATI, M. D., PIFANELLI, A. & LANZA,
G. (1976) Detection and dynamic localisation
of oestradiol receptor complexes in intact target
cells by immuno-fluorescent technique. J. Steroid
Biochem, 7, 505.
PERTSCHUK, L. P., GAETJENS, E., CARTER, A. C.,
BRIGATI, D. J., KIM, D. S. & FEALY, T. E. (1979)
An improved histochemical method for detection
of oestrogen receptors in mammary cancer.
Am. J. Clin. Pathol., 71, 504.
WALKER, R. A., CovE, D. H. & HOWELL, A. (1980)
Histological detection of oestrogen receptor in
human breast carcinoma. Lancet, i, 171.